Thursday, May 09, 2019

MONOPOLY CAPITALISM
GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on Thursday as it approved the deal.

No comments:

Post a Comment